Vertigo, a prevalent clinical symptom, often poses diagnostic challenges due to its complex pathophysiology. This article aims to provide a comprehensive clinical approach to understanding and managing vertigo.
Vertigo is a sensation of movement, typically perceived as a spinning sensation, which can be a symptom of various disorders affecting the vestibular system. It is vital to distinguish vertigo from other forms of dizziness, such as presyncope and disequilibrium, to ensure accurate diagnosis and treatment.
The clinical evaluation of vertigo includes a thorough patient history, physical examination, and, if necessary, diagnostic testing. The patient's description of their symptoms can often provide valuable clues to the underlying cause. Timing, triggers, and associated symptoms should be carefully assessed.
Diagnostic tests, such as electronystagmography (ENG), videonystagmography (VNG), and magnetic resonance imaging (MRI), can help identify the underlying cause. Central causes of vertigo, such as stroke or multiple sclerosis, typically require neuroimaging for diagnosis.
Management of vertigo depends on the underlying cause. Vestibular suppressants can provide symptomatic relief, but long-term use can hinder central compensation. Vestibular rehabilitation therapy (VRT) is often beneficial, particularly for peripheral causes of vertigo. In severe cases, surgical intervention may be required.
Vertigo is a complex clinical symptom requiring a comprehensive and systematic approach for effective management. Proper understanding of its pathophysiology, careful clinical evaluation, appropriate diagnostic testing, and targeted treatment strategies can significantly improve patient outcomes.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation